Structural and biophysical insights into the role of CD4 and CD8 in T cell activation

T cell receptors (TCRs) recognize peptides presented by MHC molecules (pMHC) on an antigen-presenting cell (APC) to discriminate foreign from self-antigens and initiate adaptive immune responses. In addition, T cell activation generally requires binding of this same pMHC to a CD4 or CD8 co-receptor,...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 4; p. 206
Main Authors Li, Yili, Yin, Yiyuan, Mariuzza, Roy A
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 01.01.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:T cell receptors (TCRs) recognize peptides presented by MHC molecules (pMHC) on an antigen-presenting cell (APC) to discriminate foreign from self-antigens and initiate adaptive immune responses. In addition, T cell activation generally requires binding of this same pMHC to a CD4 or CD8 co-receptor, resulting in assembly of a TCR-pMHC-CD4 or TCR-pMHC-CD8 complex and recruitment of Lck via its association with the co-receptor. Here we review structural and biophysical studies of CD4 and CD8 interactions with MHC molecules and TCR-pMHC complexes. Crystal structures have been determined of CD8αα and CD8αβ in complex with MHC class I, of CD4 bound to MHC class II, and of a complete TCR-pMHC-CD4 ternary complex. Additionally, the binding of these co-receptors to pMHC and TCR-pMHC ligands has been investigated both in solution and in situ at the T cell-APC interface. Together, these studies have provided key insights into the role of CD4 and CD8 in T cell activation, and into how these co-receptors focus TCR on MHC to guide TCR docking on pMHC during thymic T cell selection.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Bruno Laugel, Cardiff University, UK
Reviewed by: Paula Kavathas, Yale University, USA; Cheng Zhu, Georgia Institute of Technology, USA; Simon John Davis, University of Oxford, UK; Rose Zamoyska, University of Edinburgh, UK
This article was submitted to Frontiers in T Cell Biology, a specialty of Frontiers in Immunology.
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2013.00206